ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,420Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 559

$529K Total Retail Price of All Prescriptions

Rank: 27 out of 559

387 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 387 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,174 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
OMEPRAZOLE 517 401 1 4
LISINOPRIL 495 427 2 1
LEVOTHYROXINE SODIUM 409 359 3 2
AMLODIPINE BESYLATE 370 331 4 6
HYDROCODONE-ACETAMINOPHEN 321 245 S3 5 7
CARVEDILOL 268 208 6 38
FUROSEMIDE 260 226 7 11
POTASSIUM CHLORIDE 260 223 7 23
LOVASTATIN 206 171 9 10
CLOPIDOGREL 203 183 10 51
METFORMIN HCL 181 131 11 5
GLIPIZIDE 157 108 12 31
PLAVIX 153 141 13 76
CLONIDINE HCL 153 114 13 68
ATORVASTATIN CALCIUM 153 130 13 20
JANUVIA 151 89 16 50
TAMSULOSIN HCL 148 126 17 25
FLUTICASONE PROPIONATE 147 90 18 22
SIMVASTATIN 144 112 19 3
SERTRALINE HCL 138 100 20 19
GLYBURIDE 133 108 R 21 45
ENALAPRIL MALEATE 131 113 22 66
CHLORTHALIDONE 129 88 23 100
LANTUS 124 98 24 40
EVISTA 115 97 25 131
PRAVASTATIN SODIUM 114 94 26 35
LOSARTAN POTASSIUM 111 111 27 14
TRAMADOL HCL 111 99 27 27
GABAPENTIN 109 69 29 9
METOPROLOL SUCCINATE 106 85 30 16
ZOLPIDEM TARTRATE 105 68 31 17
CILOSTAZOL 103 90 32 208
CRESTOR 100 94 33 33
FINASTERIDE 99 87 34 59
NEXIUM 99 68 34 57
ALENDRONATE SODIUM 91 85 36 13
METOPROLOL TARTRATE 89 86 37 12
ISOSORBIDE MONONITRATE ER 77 76 38 120
SPIRIVA 71 47 39 67
WARFARIN SODIUM 70 70 40 24
RANITIDINE HCL 69 57 41 26
AMOX TR-POTASSIUM CLAVULANATE 69 57 41 98
INSULIN SYRINGE 68 47 43 65
DIOVAN 66 54 44 55
ACARBOSE 60 31 45 236
PREDNISONE 57 49 46 49
HYDROCHLOROTHIAZIDE 56 43 47 8
ALLOPURINOL 55 52 48 34
PREMARIN 52 38 R 49 97
ATENOLOL 51 45 50 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.